These data collectively lead us to propose that the increase in RGS2 expression is enough to trigger insulin resistance in endothelial cells, and uncontrolled glycemia in T2DM patients correlates with a strong increase in RGS2 protein expression level in platelets. The gene discussed is RGS2; the disease is type 2 diabetes mellitus.